drugset / Trial / NCT05368376

Is Labetalol More Effective Than Metoprolol for Controlled Hypotensive Anesthesia During Endoscopic Nasal Surgeries?

NCT05368376

Phase 4 Completed 60 enrolled Damanhour Teaching Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Background: Mucosal bleeding is the most frequent complication with endoscopic nasal surgeries, as it interferes with the optimal visualization of the intranasal anatomy, leading to increased complications, operation duration, and blood loss. There are several pharmacological techniques for the appropriate control of intraoperative bleeding. Objectives: To compare the safety and efficacy of oral labetalol versus oral metoprolol as a premedication for controlled hypotensive anesthesia during endoscopic nasal surgeries. Patients and Methods: This is a randomized, double-blind, phase four, comparative clinical trial; carried out on 60 patients, who were candidates for endoscopic nasal surgeries under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group L, received oral labetalol, and group M, received oral metoprolol.

Timeline

Start
2021-04-01
Primary completion
2022-10-01
Completion
2022-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Labetalol Small molecule 200 mg Oral
Comparator Metoprolol Other / unclassified 100 mg Oral

Indications